Thank you to Sr. Sailor for the highlighted article above, which also tells us that there's also supply chain snag for the newly approved LUTETIUM-177 treatment components.
We've all been following its recent approval for metastatic prostate cancer, in recent weeks.
The article states it is hoped the supply will be restored in six weeks.
It also stated this will impact the supply for six weeks, INCLUDING the supply needed during ongoing clinical trials.
I'm envisioning large medical campuses ---- such as Mayo Clinic or Emory or M.D. Anderson or Dana-Farber or Siteman --- now facing the news of supply chain issues for the contrast dye used daily in THOUSANDS of diagnostic scans.
Each time I visit Mayo Clinic for follow-up scans, contrast dye is almost invariably used in the process.
There are patients who fly in from all parts of the globe for scans --- with appointments that were booked months ago. I have met fellow patients from faraway countries, when I visit Mayo Clinic.
For someone just getting ready to start LUTETIUM-177 treatments - or who was in the middle of a clinical trial --- this LUTETIUM-177 shortage is critical.
It reminds me of a friend of mine, who was in the middle of chemo infusions - a few years ago. A major hurricane slammed Haiti or Puerto Rico, where an essential chemotherapy component was produced.
His chemo treatments were put on hold, until Dr. Kwon from Mayo Clinic moved "HEAVEN & EARTH" to obtain enough supplies, for his series of treatments. It was a critical situation.
I can't even describe the stress, worrisome thoughts, and anxiety my friend experienced due to that "supply chain" issue.
My best to each & all - and let's hope the medical supply chain becomes strengthened!
CYCLONE --- # Iowa State University
Post Edited (Cyclone-ISU) : 5/19/2022 9:09:07 AM (GMT-6)